Abstract
Aims
The association of dysfunctional bowel elimination with lower urinary tract symptoms is well known in children, but not in adults. It was our objective to assess lower urinary tract symptoms (LUTS) in women that report difficult defecation (DD).
Methods
This is a secondary analysis of 2812 women, aged 35–64, who participated in a telephone interview. All subjects were asked “When you move you bowels, does the stool come out easily?” DD was considered present in those answering “no”. All subjects were queried regarding LUTS, urinary infections in the past year, self perceived health status, medical history and demographics. Symptoms of stress incontinence (5 items), urge incontinence (5 items) and the impact of these symptoms on their quality of life were solicited from subjects reporting more than 12 episodes of incontinence in one year.
Results
DD was reported by 10.4% (290/2790) of women. Women with DD had higher LUTS than those who did not: nocturia (mean 1.8 ± 0.1 vs. 1.3 ± 0.0), urgency (47.6 vs. 29.2%), increased daytime frequency (mean 8.2 ± 0.3 vs. 7.2 ± 0.1), dysuria (22.9% vs. 13.7%), and a sensation of incomplete bladder emptying (55.6% vs. 28.2%). DD women were more often menopausal, reported a fair or poor self reported health status, and had a higher number of comorbidities, less formal education and lower annual household income.
Conclusions
Women with symptoms of DD have an increased rate of LUTS, consistent with the diagnosis of overactive bladder without incontinence. The pathophysiology underlying this association is worthy of future research.
Keywords: Overactive Urinary Bladder, Defecation, Urinary tract infections, Urinary incontinence, Nocturia, Dysuria
Aims
An association in children between constipation and lower urinary tract symptoms is a relatively recently appreciated phenomenon (1). In the majority of children, functional rather than anatomical abnormalities are often responsible for urinary tract infections, urinary incontinence, urgency and frequency. These neurologically normal children were previously labeled as “dysfunctional voiders” and were given bladder retraining and timed voiding as treatment. However, this perception changed dramatically after it was shown that constipation and voluntary fecal retention was actually the major contributor to their urinary symptoms. By treating the constipation daytime incontinence was relieved in 90% of children and recurrence of urinary tract infections was eliminated (1). The constellation of childhood symptoms of constipation, fecal incontinence, and painful bowel movements combined with urinary symptoms of frequent urinary tract infections, urge incontinence, urgency and frequency in the anatomically normal child is now called dysfunctional elimination syndrome (2).
There exists some data about the link between bowel and bladder symptoms in the adult (3,4), but unless a woman is being seen by a physician who specialized in pelvic medicine there is usually no one physician who queries her about both of these symptoms.
Two studies have investigated the impact of having had dysfunctional elimination as a child on symptoms as an adult. Both of these studies have found that adult women with lower urinary tract symptoms (LUTS) reported more childhood dysfunctional elimination (DE) symptoms than women who did not (5,6). Little is known about the urologic impact of adult dysfunctional bowel elimination, or difficult defecation in adults.
Based on clinical observations and the known association between bowel and bladder symptoms in children we hypothesized that women with difficult defecation would have more LUTS than women who do not. Our aim was to assess if LUTS are more common in women that report difficult defecation. The LUTS of particular interest included overactive bladder (urgency with or without urgency incontinence, frequency and nocturia) and stress incontinence.
Methods
This is a secondary analysis of 2,812 community dwelling women, aged 35–64, who participated in a telephone interview as part of an epidemiologic study of urinary incontinence (UI) prevalence among White and Black women(7). These women were sampled from 12,541 telephone records from three southeast Michigan counties with the study goal of interviewing 1500 black women and 1000 white women. The research protocol was approved by the institutional review board of the University of Michigan Medical School (IRB#2000-0824).
Information brochures and a letter introducing the study were mailed to the address associated with the telephone number and soon thereafter a trained female professional telephone interviewer from the Survey Research Center of the University of Michigan Institute for Social Research called the household to screen for eligible participants. Inclusion criteria were women between the ages of 35 and 64 who self-identified as black or white race who had not been pregnant in the past 12 months. Eligible women who consented verbally were assessed for demographic characteristics, health history, lifestyle factors, obstetric and gynecologic history and lower urinary tract symptoms including urinary incontinence.
The protocol for the sampling of the population and for the questionnaire survey has been described (7). There was a 69% response rate.
All subjects were asked “When you move your bowels, does the stool come out easily?” Difficult defecation (DD) was considered present in those answering “no”. The answers of women with and without DD were compared with respect to number of bowel movements per week, bladder storage symptoms per ICS Standardized terminology (number of nocturia episodes, the presence of urgency, and UI), number of daytime voids (frequency), presence of urinary infections in the past year, dysuria, feelings of incomplete emptying, and the need to locate the nearest toilet as soon as arriving at a new place. The women were also asked to rate their self perceived health status as excellent, very good, good, fair or poor. Any woman who reported leaking urine 12 or more times in the past 12 months was asked additional questions regarding their urine loss. These included five items specific to symptoms of stress incontinence, and five items specific to urge incontinence as well as the impact of these symptoms on their quality of life as assessed by the incontinence impact questionnaire-7 (IIQ-7)(8). This questionnaire yields a summed score ranging from 0 to 100 with higher scores indicating a greater degree of distress.
Student t-tests and chi square analysis were used to evaluate the association of DD with demographics, lower urinary tract symptoms, bowel movement frequency, lower urinary tract symptoms and perception of health status. Multivariable logistic regression was used to calculate odds ratios adjusted for age, household income, education, hysterectomy status, previous prolapse surgery, and self perceived health status. P values <0.05 were considered statistically significant. Stata (version 9.2, College Station Texas) was used for all analyses.
Results
Difficult defecation was reported by 10.4% (290/2790) of women enrolled in the study. Women with DD were more likely than were those without to have three or fewer bowel movements per week (46.5 v. 11.7%, adjusted OR 5.8, 95% CI 4.2–8.0). Fecal incontinence was not more likely to be experienced by women with DD compared to those without DD (18.8 v 13.4%, adjusted OR 1.2, 95% CI .81–1.8)
The demographic data of the women with and without DD are presented in Table I. Women with DD reported a higher mean number of comorbidities and were more likely than those without DD to be post menopausal, to have had a hysterectomy or prolapse surgery, to have not completed the twelfth grade, to report an income of less than $25 000, and to report a self perceived health status of “fair” or “poor”. The groups did not differ with respect to age, mean parity, marital status, race, past incontinence surgery or the use of estrogen replacement.
Table 1.
Demographics, health history and self perceived health status of entire cohort with or without difficult defecation.
| Demographics/health | Difficult defecation n=2500 | No difficult defecation n=290 | P value |
|---|---|---|---|
|
| |||
| Age (years) | 49.6 | 49.9 | 0.57 |
|
| |||
| Mean Parity | 2.81 | 2.89 | 0.89 |
|
| |||
| Education 12th grade or less completed | 37.50% | 28.76% | 0.007 |
|
| |||
| Household income <25K/year | 30.05% | 20.45% | 0.017 |
|
| |||
| Marital status – married | 46.3% | 48.5% | 0.189 |
|
| |||
| Race – African American | 65.97% | 68.72% | 0.343 |
|
| |||
| Past hysterectomy | 31.25% | 21.65% | <0.001 |
|
| |||
| History of prolapse surgery | 7.64% | 4.00% | 0.004 |
|
| |||
| History of incontinence surgery | 3.13% | 1.71% | 0.094 |
|
| |||
| Post menopausal | 61.75% | 48.55% | <0.001 |
|
| |||
| Estrogen replacement | 14.04% | 10.73% | 0.093 |
|
| |||
| Number of comorbidities ±se (n=2733) | 1.9 ± 0.1 | 1.4 ± 0.02 | <0.001 |
|
| |||
| Self perceived health status (n=2750): | |||
| Excellent to very good | 31.3% | 47.6% | 0.04 |
| Good | 34.0% | 35.1% | |
| Fair/poor | 34.7% | 17.3% | |
Lower urinary tract and bowel symptoms are reported in Table 2. The constellation of symptoms commonly referred to as “dry” overactive bladder which includes urinary urgency, frequency, and nocturia was more common among women with DD. Women with DD were also more likely to have a sensation of incomplete emptying, dysuria, and urinary tract infections than were those without DD.
Table 2.
Lower urinary tract symptoms in group with difficult defecation compared to those without.
| Lower Urinary Tract Symptoms | Difficult Defecation | |||
|---|---|---|---|---|
| Data presented are mean ± std error unless otherwise noted | Present | Absent | Unadjusted OR* (95% CI) | Adjusted OR** (95% CI) |
| Frequent strong sudden urges to urinate (n=2739) | 47.6% | 29.2% | 2.20 (1.71–2.81) | 2.43 (1.79–3.31) |
| Nocturia episodes (n=2741) | 1.8 ± 0.1 | 1.3 ± 0.02 | 1.32 (1.20–1.44) | 1.31 (1.17–1.48) |
| Daytime urinary frequency episodes (n=2750) | 8.2 ± 0.3 | 7.2 ± 0.1 | 1.06 (1.03–1.09) | 1.06 (1.02–1.10) |
| Locate nearest toilet as soon as arriving at a new place (n=2739) | 32.17% | 18.7% | 2.06 (1.58–2.67) | 2.09 (1.51–2.91) |
| Dysuria (n= 2750) | 22.9% | 13.7% | 1.41 (1.12–1.79) | 1.42 (1.04–1.94) |
| UTI in past year (n= 2750) | 18.8% | 12.2% | 1.67 (1.22–2.31) | 1.64 (1.11–2.44) |
| Sense of incomplete emptying (n= 2743) | 55.6% | 28.2% | 3.19 (2.48–4.09) | 3.31 (2.43–4.52) |
p < .004 for all values
Logistic regression controlling for age income education less than grade 12, history of hysterectomy, history of prolapse surgery.
Urinary incontinence was common among women with DD. Subsets of women reporting symptoms were evaluated in a stepwise fashion based on severity of symptoms (Figure 1) Women with DD were more likely than those without DD to report that they had experienced any urinary incontinence (61.1% v 42.9%, adjusted OR 2.4, 95% CI 1.6–2.7). Amongst those reporting any urinary incontinence, women with DD were also more likely than those without DD to report that they experienced “more than 12 episodes in the last year” (56% v 44%, adjusted OR 1.6, 95% CI 1.1–2.3). Those women who answered yes to both of these questions (n= 563) were further queried about symptoms of stress and urgency associated incontinence. Although the rates of specific symptoms did not differ (Table 3), the perceived impact of these symptoms on quality of life was much greater among those with DD (mean IIQ-7 score ± SD: 33.5 ± 26.4 vs. 23.7 ± 23.8 p=.004). The incontinent group was also asked “how are you managing your incontinence?” In the DD group 9.56% indicated that they were taking medication (specific type not specified) and in the DD absent group 8.01% with P value of 0.8.
Figure 1.
Table 3.
Urinary incontinence symptoms amongst women who have >12 urinary incontinence episodes per year (n=563).
| Urinary Incontinence | Difficult Defecation | P value | |
|---|---|---|---|
| Yes | No | ||
| SUI: with cough/laugh/sneeze | 49.5% | 48.4% | 0.9 |
| SUI: with lifting | 9.2% | 10.4% | 0.3 |
| SUI: straining | 7.2% | 9.1% | 0.06 |
| SUI: exercise | 9.3% | 11.9% | 0.5 |
| SUI: sexual incontinence | 2.1% | 4.1% | 0.5 |
| UUI: when you have a cold | 9.3% | 6.0% | 0.4 |
| UUI: when you put keys in lock | 18.6% | 21.6% | 0.9 |
| UUI: hearing water run | 12.4% | 13.3% | 0.8 |
| UUI: with little warning | 25.8% | 23.4% | 0.2 |
| UUI: can’t find toilet | 23.7% | 14.8% | 0.2 |
SUI= stress urinary incontinence, UUI= urgency urinary incontinence
Discussion
Women with symptoms of DD have an increased rate of bladder storage symptoms, consistent with the diagnosis of overactive bladder without incontinence, or so called “dry OAB”. They have more incontinence, but it is not specifically urgency or stress incontinence. These women also report more dysuria, urinary tract infections, and a sensation of incomplete emptying. Symptoms of urinary incontinence are more common among women with DD and these symptoms have a more negative impact on their quality of life as measured by the IIQ-7. This constellation of symptoms is similar, but not identical to pediatric dysfunctional elimination.
Pediatric dysfunctional elimination is characterized by the combination of bowel and bladder symptoms such as fecal incontinence, constipation, urinary tract infections (UTI), urgency, frequency and urinary incontinence. These symptoms together are called dysfunctional elimination and are a well-known entity in pediatrics (2). The root cause of these combined symptoms is felt to be primarily constipation. When constipation is successfully treated in children with DE, without any specific treatment for the urinary symptoms, 89% of the children are cured of daytime urinary incontinence, 63% have disappearance of their of nighttime incontinence and all anatomically normal children have disappearance of UTIs (1). Empiric support such as this is not available in women but there is epidemiologic evidence to suggest that a constellation of symptoms similar to those seen in children can affect women.
A relationship between adult Urogynecology patients and childhood dysfunctional elimination has been established. Bower et al surveyed 191 women attending a urogynecology clinic and 251 women attending other clinics about their current dysfunctional elimination symptoms and those when they were children. There were significantly higher dysfunctional elimination scores as children in women who were attending the urogynecology clinic and 41.7% of the UG women could be labeled as DE now. The authors concluded that a history of DE syndrome as a child results in more bowel and bladder problems as an adult (6). Minassian et al. found similar results when they surveyed 170 women attending gynecology clinics. The women who reported a history of childhood dysfunctional elimination currently had more urinary frequency, urgency, SUI and UUI (5).
There is also the possibility that dysfunctional elimination syndrome that occurs in children is a completely different disorder altogether than the constellation of symptoms present in our adult population. In the few articles that address both bowel and bladder disorders together, symptoms of OAB and anal incontinence or constipation were found to overlap significantly, but the main risk factor for these combined symptoms was uterovaginal prolapse (9). It has been reported that 10–40% of women with anorectal incontinence have SUI or prolapse (10,11). However, in this analysis the difference in bladder symptoms held true when controlling for prolapse in the logistic regression.
The question arises: what about difficult defecation, or difficulty emptying stool from the rectum, could possibly cause overactive bladder symptoms combined with other LUTS? Rectal distention from a stool bolus is the normal stimulus for defecation. If evacuation is delayed one has to contract the external sphincter and puborectalis to cause the fecal urgency to subside until the next fecal bolus arrives. Over time, if this behavior of maintaining chronic anal sphincter tone persists, the rectum gets over distended and the pelvic floor becomes hypertonic and this may persist. This is referred to as fecal hoarding in children and is felt to be a major contributor to childhood OAB symptoms (12).
If the rectum does not empty well the fecal mass that is stored in the rectum and sigmoid may exert pressure on the bladder wall, decreasing functional bladder capacity like a gravid uterus compresses the bladder during pregnancy leading to overactive bladder symptoms (13) or that the stretch receptors in the bladder wall are stimulated by the fecal mass triggering uninhibited detrusor contractions (12, 14). It is also possible that colonic contractions may trigger detrusor contractions though a shared neurological pathway in the spinal cord or pelvic nerves (15). This has also been seen in an animal model where colonic contractions from acute colitis increases voiding symptoms in rats (16,17).
There may be a central nervous system alteration that is responsible for these combined bowel and bladder symptoms. Afferent nerves in the sigmoid, rectum and bladder all send information to the spinal cord via the pelvic nerve and pelvic parasympathetic nerves mediate both bowel and bladder emptying. Therefore an afferent neural pathway disorder could explain the combined hypersensitive bowel and bladder occurring together. Sacral nerve stimulation has had good success in treating both urgency and frequency symptoms as well as chronic defecation disorders, despite identical placement of the stimulation lead in the S3 foramina for both indications. Therefore, this theory of a common neurological pathway is plausible (18).
Many other genitourinary symptoms have been shown to overlap in a similar fashion as the bowel and bladder symptoms in this analysis. Bladder symptoms that define interstitial cystitis/painful bladder syndrome (IC/PBS) and bladder outlet obstruction have been shown to overlap and exist together more frequently than would be expected by chance in the Boston Area Community Health Survey. This survey queried over 3000 racially diverse community dwelling women and found that 0.5% of the women reported pure symptoms of IC/PBS, 11.4% reported pure obstructive type symptoms and 1.1% reported both, making the overlap of symptoms more than twice as prevalent as pure IC/PBS symptoms (19).
There are several factors that should be kept in mind in interpreting the results of this analysis. This group of women was recruited from women 35–64 years of age in a small geographical area in Michigan. The generalizability of the results to women of other ages or living in other parts of North America remains to be defined. Also no Latina or Asian-American women were recruited so these results cannot be applied to these populations. This study was not designed to measure defecatory dysfunction specifically and a more complete bowel questionnaire is needed to fully evaluate these symptoms. Our hypothesis that this disorder may be related to childhood dysfunctional elimination is not assessable since childhood elimination symptoms were not asked of this population.
This association between bowel and bladder symptoms in women has clinical implications. It is well known that treatment of these bowel symptoms in children dramatically reduces urinary infections and urinary incontinence (20). The treatment of these bowel symptoms in women could potentially be equally efficacious. It is our suggestion that all women with OAB symptoms should be queried about their bowel symptoms and any defecatory dysfunction addressed simultaneously with the OAB due to their probable interrelation. Unfortunately the mainstay of pharmacological treatment for OAB is antimuscarinic agents who have the potential side effect of constipation in approximately 7% (21). Further study needs to be done to confirm that treatment of the bowel symptoms in the adult female will improve their bladder symptoms these measures are certainly not harmful and are potentially beneficial not only to the bowel, but to bladder symptoms.
Conclusion
Women with symptoms of defecatory dysfunction have an increased rate of bladder storage symptoms, consistent with the diagnosis of overactive bladder without urge incontinence, or dry OAB. Understanding the pathophysiology underlying this association and exploring treatment options that address these combined symptoms is worthy of future research.
Acknowledgments
Funding: This research was supported by NIH R01HD/AG41123-01 with additional Investigator support from Office for Research on Women’s Health and the National Institute of Child Health and Human Development SCOR 1 P50 HD044406
Footnotes
Dirk De Ridder led the review process.
Contributor Information
Anne P. Cameron, Department of Urology, University of Michigan, Ann Arbor, MI
Dee E. Fenner, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI
John O. L. DeLancey, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI
Daniel M. Morgan, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI
References
- 1.Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997 Aug;100(2 Pt 1):228–232. doi: 10.1542/peds.100.2.228. [DOI] [PubMed] [Google Scholar]
- 2.Feng WC, Churchill BM. Dysfunctional elimination syndrome in children without obvious spinal cord diseases. Pediatr Clin North Am. 2001 Dec;48(6):1489–1504. doi: 10.1016/s0031-3955(05)70387-4. [DOI] [PubMed] [Google Scholar]
- 3.van Gerwen M, Schellevis F, Lagro-Janssen T. Comorbidities associated with urinary incontinence: a case-control study from the Second Dutch National Survey of General Practice. J Am Board Fam Med. 2007 Nov-Dec;20(6):608–610. doi: 10.3122/jabfm.2007.06.070151. [DOI] [PubMed] [Google Scholar]
- 4.Damon H, Schott AM, Barth X, Faucheron JL, Abramowitz L, Siproudhis L, et al. Clinical characteristics and quality of life in a cohort of 621 patients with faecal incontinence. Int J Colorectal Dis. 2008 Sep;23(9):845–851. doi: 10.1007/s00384-008-0489-x. [DOI] [PubMed] [Google Scholar]
- 5.Minassian VA, Lovatsis D, Pascali D, Alarab M, Drutz HP. Effect of childhood dysfunctional voiding on urinary incontinence in adult women. Obstet Gynecol. 2006 Jun;107(6):1247–1251. doi: 10.1097/01.AOG.0000190222.12436.38. [DOI] [PubMed] [Google Scholar]
- 6.Bower WF, Yip SK, Yeung CK. Dysfunctional elimination symptoms in childhood and adulthood. J Urol. 2005 Oct;174(4 Pt 2):1623–7. doi: 10.1097/01.ju.0000176599.91836.12. discussion 1627–8. [DOI] [PubMed] [Google Scholar]
- 7.Fenner DE, Trowbridge ER, Patel DA, Fultz NH, Miller JM, Howard D, et al. Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol. 2008 Apr;179(4):1455–1460. doi: 10.1016/j.juro.2007.11.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14(2):131–139. doi: 10.1002/nau.1930140206. [DOI] [PubMed] [Google Scholar]
- 9.Ng SC, Chen YC, Lin LY, Chen GD. Anorectal dysfunction in women with urinary incontinence or lower urinary tract symptoms. Int J Gynaecol Obstet. 2002 May;77(2):139–145. doi: 10.1016/s0020-7292(02)00026-7. [DOI] [PubMed] [Google Scholar]
- 10.Delechenaut P, Leroi AM, Weber J, Touchais JY, Czernichow P, Denis P. Relationship between clinical symptoms of anal incontinence and the results of anorectal manometry. Dis Colon Rectum. 1992 Sep;35(9):847–849. doi: 10.1007/BF02047871. [DOI] [PubMed] [Google Scholar]
- 11.Jackson SL, Weber AM, Hull TL, Mitchinson AR, Walters MD. Fecal incontinence in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 1997 Mar;89(3):423–427. doi: 10.1016/S0029-7844(96)00499-1. [DOI] [PubMed] [Google Scholar]
- 12.Franco I. Overactive bladder in children. Part 2: Management. J Urol. 2007 Sep;178(3 Pt 1):769–74. doi: 10.1016/j.juro.2007.05.076. discussion 774. [DOI] [PubMed] [Google Scholar]
- 13.Belman AB, King LR, Kramer LA, editors. Clinical Pediatric Urology. London: Martin Dunitz Ltd; 2002. [Google Scholar]
- 14.Fernandes E, Vernier R, Gonzalez R. The unstable bladder in children. J Pediatr. 1991 Jun;118(6):831–837. doi: 10.1016/s0022-3476(05)82191-2. [DOI] [PubMed] [Google Scholar]
- 15.Warne SA, Godley ML, Wilcox DT. Surgical reconstruction of cloacal malformation can alter bladder function: a comparative study with anorectal anomalies. J Urol. 2004 Dec;172(6 Pt 1):2377–81. doi: 10.1097/01.ju.0000145201.94571.67. discussion 2381. [DOI] [PubMed] [Google Scholar]
- 16.Pezzone MA, Liang R, Fraser MO. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005 Jun;128(7):1953–1964. doi: 10.1053/j.gastro.2005.03.008. [DOI] [PubMed] [Google Scholar]
- 17.Ustinova EE, Fraser MO, Pezzone MA. Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol. 2006 Jun;290(6):F1478–87. doi: 10.1152/ajprenal.00395.2005. [DOI] [PubMed] [Google Scholar]
- 18.Jarrett ME. Neuromodulation for constipation and fecal incontinence. Urol Clin North Am. 2005 Feb;32(1):79–87. doi: 10.1016/j.ucl.2004.09.010. [DOI] [PubMed] [Google Scholar]
- 19.Barry MJ, Link CL, McNaughton-Collins MF, McKinlay JB Boston Area Community Health (BACH) Investigators. Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women. BJU Int. 2008 Jan;101(1):45–51. doi: 10.1111/j.1464-410X.2007.07191.x. [DOI] [PubMed] [Google Scholar]
- 20.Nevéus T. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. The Journal of urology. 2006;176(1):314. doi: 10.1016/S0022-5347(06)00305-3. [DOI] [PubMed] [Google Scholar]
- 21.Diokno AC, Appell RA, Sand PK, Dmochowski RR, Gburek BM, Klimberg IW, et al. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc. 2003 doi: 10.4065/78.6.687. [DOI] [PubMed] [Google Scholar]

